- Inari exclusively licensed a portfolio of epigenetics patents from the University of California, Los Angeles.
- The agreement provides Inari's Seed Foundry™ product development system with new, proprietary ways to improve plant performance.
UCLA TDG is happy to share that Bone Biologics, UCLA TDG’s licensee receives Human Research Ethics Committee (HREC) approval for the first center of a multicenter pilot clinical trial to evaluate NB1 (NELL-1/DBX®) in Australia. This product stems from a UCLA research led by Dr. Chia Soo., Dr. Kang Ting and Dr. Ben Woo and was Licensed from UCLA TDG.
UCLA Technology Development Group is pleased to present the December 2018 issue of Innovation Magazine.
Welcome to the second Innovation Magazine from the UCLA Technology Development Group. In this issue we highlight UCLA TDG accomplishments in recent months! Our many projects are fully under way and we have established partnerships at multiple levels within the UC ecosystem, investors and with industry professionals. Featured in this issue of the magazine is storytelling and background on the TDG team, our recent deal making, what we do and how we’ve arrived at our success and growth.
In this episode, Kirsten Leute speaks with Amir Naiberg, Associate Vice Chancellor and CEO & President, UCLA Technology Development Corporation, about his experiences in technology transfer in Israel and the US.
Eighteen professors, researchers and clinicians at UCLA have been named recipients of awards from the 2017 UCLA Innovation Fund Biomedical Competition, which was established to quickly move technologies from idea to the marketplace and bridge the gap between academia and industry-investor interest to provide benefit to patients and the public.
Ragan Robertson, Tech Transfer and Information Systems Officer for the UCLA Technology Development Group, has been recognized by AUTM (Association of University Technology Managers) with the 2018 Bayh-Dole Award for his efforts to foster and promote intellectual property activities on behalf of the university and nonprofit community. CONGRATULATIONS, RAGAN!
Falcon Computing Solutions and the UCLA Center for Precision Medicine today announced a collaboration that will accelerate innovation and the adoption of cloud-based genomics sequencing solutions. Falcon is conducting initial product testing, benchmarking and optimization at UCLA based on the industry standard GATK best practices pipeline, and is receiving valuable feedback from the UCLA researchers and scientists that allow for product optimization. The joint activity builds upon an existing relationship between UCLA and Falcon – a UCLA spinout co-founded by Dr.
20 startups, 21 new staff members, and $41.8 million in ISR in the 2017 fiscal year. Learn more about what we've accomplished, and what we hope to do next in the TDG Newsletter, Vol.1.